The Kaplan Laboratory focuses on transcription factors involved in the development of T helper cell subsets and how those cells contribute to inflammation in allergic and autoimmune diseases. Overall, the goal of this work is to identify biomarkers for the development of personalized medicine and disease intervention.
The Cook-Mills Laboratory explores the genetic and environmental factors that contribute to the development of allergic disease with hopes of developing regulatory therapies to prevent severe allergic reaction.
The Conway Laboratory seeks to identify the mechanisms and cell lineages responsible for cardiopulmonary disease development and transgenically and/or pharmacologically current the various structural and functional defects.
The Tepper Laboratory focuses on the lung structure and function related to airway hyper-reactivity as well as lung growth and maturation in vivo and in vitro.
The Turner Lab studies the interaction between skin injury, inflammation and wound healing. The goal of the Turner Lab is to discover new molecular pathways that promote inflammatory skin diseases and impair wound healing in order to translate these discoveries into new and better treatments for patients.
The Yang Laboratory seeks to identify key molecular and metabolic components involved in the initiation and progression of allergic diseases with the long-term goal of developing novel treatment strategies for allergic disease.
- Helping cancer survivors get “back to life” after treatment with new, free wellness center
- $1.8 million NIH grant funds IU researcher’s work on mobile compression device
- First patient to try FDA-approved drug for amyloidosis is thankful
- Researchers bring big ideas to national conference
- IU School of Medicine research awarded military grant funding for wound dressing study